Interviews

Pharmacy students discuss how they use social media platforms like TikTok, Instagram, and YouTube to reinforce their classroom learning.

Robert Walker discusses the updated COVID-19 vaccines targeting the new JN.1 lineage of the virus and the challenges of addressing vaccine hesitancy to protect individuals and communities.

In an initiative to close vaccine gaps in local Missouri communities, pharmacists and community health workers proved essential.

In an interview with Pharmacy Times, Jasmine Perry describes her idea of an effective health care delivery model and why research can have a huge impact at the policy level.

The Alzheimer disease treatment landscape is evolving with new FDA-approved antibody therapies and advancements in biomarker testing to enable earlier diagnosis and intervention.

Drawing on years of experience, Rina Shah explains how sustainable care models are essential for a thriving pharmaceutical industry.

In an interview with Pharmacy Times, Jon Easter discusses the need for pharmacy to align as a profession to achieve policy and research goals.

Tune into this episode of “Public Health Matters” to learn about how Healthcare Advocate Summit, created by advocates for advocates, is involved in the discussion on improving access to health care.

President of NACDS, Steve Anderson, discusses how the events at Total Store Expo reflect on the association's goals of innovation and a focus on public policy.

Sara Roszak recounts the Annual NACDS Foundation Dinner and their role in implementing research at the clinical level.

Brandon Newman highlights the need for balanced regulation, transparency, and real-time data access to ensure fair competition and optimal outcomes for pharmacy benefit mangers.

These pharmacies bring high-touch specialty pharmacies into local communities for patients with more complex needs.

Joseph Saseen offers valuable insights into the implications of the added performance and quality measures for patients and health care providers.

Jasmine Perry discusses the More Than a Script program in an interview with Pharmacy Times.

Brandon Newman discusses the significant influence of the "big 3" pharmacy benefit managers and the key legislative and regulatory efforts around transparency.

Steve Anderson, president and CEO of the National Association of Chain Drug Stores (NACDS), discusses memorable moments from this year's NACDS Total Store Expo.

Sara Roszak discusses her role as president of the NACDS Foundation.

Scott Biggs and Doug Long explain current trends in the pharmaceutical industry and the importance of ensuring pharmacists are informed.

Jon Easter talks about community pharmacy's role in propelling diabetes innovation and optimizing patient care.

Rina Shah discusses the importance of community pharmacy and how pharmacists can optimize care for patients.

A federal and state policy expert discusses the announcement from the Centers for Medicare & Medicaid Services on the agreement to lower prices for 10 selected drugs due to the Inflation Reduction Act.

Olivia Kinney, a national pharmacy practice manager at Kroger, discusses strategies for pharmacists to effectively address vaccine hesitancy by building trust with patients.

Tune into this episode of “Public Health Matters” to learn about how Healthcare Advocate Summit, created by advocates for advocates, is involved in the discussion on improving access to health care.

Dan Schrum discusses the integral role of pharmacy specialists in translating clinical trial results to clinical practice.

Dan Schrum highlights the crucial role of lymphodepletion in enhancing the effectiveness of CAR T cell therapy.

Pharmacists can personalize supportive care, educate patients and their caregivers, advocate for patients, and collaborate with other health care workers.

Chris Peshek of Discount Drug Mart discusses the importance of community pharmacies and the process of building relationships with patients, and how a profession in the field can be rewarding for those seeking to pursue it.

In addition to a rapid deterioration, psychosis in Alzheimer disease can also lead to poorer quality of life, damaged patient-caregiver relationships, and increased isolation.

Edward B. Lee, MD, PhD, also describes how understanding Alzheimer disease requires the integration of multiple fields including genetics, pathology, epidemiology, pharmacology, and physiology.

Tara Spires-Jones, DPhil, FMedSci, discusses how oligomeric tau clumps inside brain synapses, pointing to indirect evidence that it may be progressing through the brain by jumping between connections.